Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP increased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 102.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,465,007 shares of the company's stock after buying an additional 740,007 shares during the quarter. Henry Schein comprises approximately 0.4% of Hudson Bay Capital Management LP's portfolio, making the stock its 16th largest position. Hudson Bay Capital Management LP owned about 1.18% of Henry Schein worth $101,378,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Barclays PLC raised its holdings in shares of Henry Schein by 6.9% in the 3rd quarter. Barclays PLC now owns 286,475 shares of the company's stock valued at $20,882,000 after buying an additional 18,458 shares during the period. Franklin Resources Inc. raised its holdings in Henry Schein by 14.0% in the third quarter. Franklin Resources Inc. now owns 37,637 shares of the company's stock valued at $2,673,000 after acquiring an additional 4,621 shares in the last quarter. Principal Financial Group Inc. grew its holdings in Henry Schein by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 145,835 shares of the company's stock worth $10,631,000 after acquiring an additional 3,037 shares in the last quarter. Nordea Investment Management AB increased its position in shares of Henry Schein by 8.6% in the 4th quarter. Nordea Investment Management AB now owns 10,974 shares of the company's stock valued at $761,000 after purchasing an additional 869 shares during the last quarter. Finally, Czech National Bank lifted its position in shares of Henry Schein by 4.7% during the 4th quarter. Czech National Bank now owns 27,034 shares of the company's stock worth $1,871,000 after purchasing an additional 1,223 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company's stock.

Henry Schein Price Performance

HSIC stock traded up $0.23 on Friday, reaching $71.77. 378,460 shares of the company's stock were exchanged, compared to its average volume of 1,635,677. The stock has a fifty day moving average of $67.36 and a 200-day moving average of $71.45. The firm has a market cap of $8.74 billion, a PE ratio of 29.55, a P/E/G ratio of 2.13 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue was down .1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.10 EPS. As a group, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HSIC. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Barrington Research reduced their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. StockNews.com downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Finally, Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Henry Schein currently has an average rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.